Skip to main content
. 2014 Feb 26;9(2):e89094. doi: 10.1371/journal.pone.0089094

Table 2. Mutations found in the analyzed cohort of 738 Polish CF patients, sorted according to the position in the gene.

Exon / intron (legacy) Exon / intron (Ensembl) Protein change SVM value cDNA (HGVS nomenclature) gDNA (cDNA +132 bp) Number of PL CF chromosomes Reference a Mutations in trans
Pathogenic mutations
1 1 L15Ffs10X c.43delC 175delC 1 CFMDB 1717-1G>A
2 2 G27V −1.92 c.80G>T 212G>T 1 Novel F508del
2 2 S18RfsX16 c.54-5940_273 +10250del21kb exon2,3del21kb 66 IL19 various CF mutations
i2 i2 IVS2_Donor c.164+1G>A 296+1G>A 3 CFMDB various CF mutations
3 3 G85E −2.61 c.254G>A 386G>A 1 IL17 unknown
3 3 E60X c.178G>T 310G>T 0 IL17 x
3 3 L88IfsX22 c.262_263delTT 394delTT 0 IL17 x
4 4 E92K −1.92 c.274G>A 406G>A 2 CFMDB c.164+1G>A; c.2051-2AA>G
4 4 L101X c.302T>G 434T>G 1 CFMDB c.3717+12191C>T
4 4 K114IfsX5 c.341_353del13bp 473del13bp 1 Novel F508del
4 4 R117H −0.35 c.350G>A 482G>A 5 IL17 F508del; 2x unknown
4 4 R117C −2.07 c.349C>T 481C>T 2 CFMDB S1206X;1x unknown
4 4 L137_L138insT c.412_413insACT L138ins 1 CFMDB F508del
4 4 R153I −2.61 c.458G>T 590G>T 2 Novel F508del; c.3527delC
i4 i4 IVS4_Donor c.489+1G>T 621+1G>T 5 IL17 F508del; c.489+1G>T
5 5 L165X c.494T>A 626T>A 1 Novel F508del
i5 i5 IVS5_Donor c.579+1G>T 711+1G>T 0 IL19 x
i5 i5 IVS5_Donor c.579+3A>G 711+3A>G 2 CFMDB 2,3del21kb; c.2052-3insA
i5 i5 IVS5_Donor c.579+5G>A 711+5G>A 0 IL17 x
7 8 F311L −0.90 c.933C>G 965C>G 2 CFMDB 2x F508
7 8 G314R −0.58 c.940G>A 1072G>A 4 CFMDB various CF mutations
7 8 F316LfsX12 c.948delT 1078delT 1 IL17 unkown
7 8 R334W −2.41 c.1000C>T 1132C>T 6 IL17 various CF mutations
7 8 I336K −2.07 c.1007T>A 1139T>A 2 CFMDB 2,3de21kb; F508del
7 8 R347P −2.27 c.1040G>C 1172G>C 11 IL17 various CF mutations
i7 i8 IVS8_Donor c.1116+2T>A 1248+2T>A 1 Novel Q1412X
9 10 A455E −2.61 c.1364C>A 1496C>A 0 IL17 x
i9 i10 IVS10_Donor c.1392+1G>A 1524+1G>A 1 CFMDB c.3816-7delGT
10 11 S466X c.1397C>G 1529C>G 1 CFMDB G542X
10 11 I507del c.1519_1521delATC 1651delATC 2 IL19 F508del
10 11 F508del c.1521_1523delCTT 1654delCTT 805 IL19 various CF mutations
i10 i11 IVS11_Acceptor c.1585-1G>A 1717-1G>A 27 IL19 various CF mutations
11 12 G542X c.1624G>T 1756G>T 25 IL19 various CF mutations
11 12 G551D −1.24 c.1624G>T 1756G>T 5 IL19 various CF mutations
11 12 Q552X c.1654C>T 1786C>T 0 IL19 x
11 12 R553X c.1657C>T 1789C>T 14 IL19 various CF mutations
11 12 R560T −1.92 c.1679G>C 1811G>C 0 IL19 x
i12 i13 IVS13_Donor c.1766+1G>A 1898+1G>A 6 IL19 various CF mutations
i12 i13 IVS13_Donor c.1766+1G>C 1898+1G>C 1 CFMDB F508del
13 14 H620P −1.73 c.1859A>C 1991A>C 1 CFMDB F508del
13 14 R668C//G576A −1.61//1.73 c.2002C>T//c.1727G>C 2134C>T//1859G>C 5 b CFMDB//rs1800098 c.1585-1G>A; 4 unknown
13 14 L671X c.2012delT 2143delT 27 IL17 various CF mutations
13 14 K684SfsX38 c.2051_2052delAAinsG 2183AA>G 10 IL17 various CF mutations
13 14 K684NfsX38 c.2052delA 2184delA 0 IL17 x
13 14 Q685TfsX4 c.2052_2053insA 2184insA 15 CFMDB various CF mutationsc, 1 unknown
13 14 L732X c.2195T>G 2327T>G 1 CFMDB F508del
14A 15 R851X c.2551C>T 2683C>T 3 CFMDB various CF mutations
14A 15 I864SfsX28 c.2589_2599del11bp 2721del11bp 2 CFMDB F508del; 2,3del21kb
i14B i16 IVS16_Donor c.2657+2_2657+3insA 2789+2insA 1 CFMDB F508del
i14B i16 IVS16_Donor c.2657+5G>A 2789+5G>A 0 IL17 unkown
15 17 Y919C −1.02 c.2756A>G 2888A>G 1 CFMDB unknown
15 17 H939HfsX27 c.2817_2820delTACTC 2949delTACTC 1 Novel unkown
i15 i17 IVS17_Donor c.2908+3A>C 3040+3A>C 1 Novel F508del
i16 i18 IVS18_Donor c.2988+1G>A 3120+1G>A 0 IL19 x
17A 19 I1023_V1024del c.3067_3072delATAGTG 3199del6 0 IL19 x
i17A i19 IVS19 c.3140-26A>G 3272-26A>G 9 IL19 various CF mutations
17B 20 L1065R −1.90 c.3194T>G 3326T>G 1 CFMDB F508del
17B 20 Y1092X c.3276C>A 3408C>A 1 CFMDB R334W
i18 i21 IVS21_Donor c.3468+2_3468+3insT 3600+2insT 11 CFMDB various CF mutationsd, 1 unknown
18 21 E1126EfsX7 c.3376_3379delGAAG 3508delGAAG 1 Novel F508del
19 22 R1158X c.3472C>T 3604C>T 2 CFMDB F508del; R553X
19 22 R1162X c.3484C>T 3616C>T 1 IL17 F508del
19 22 L1177SfsX15 c.3528delC 3659delC 4 IL17 various CF mutations
19 22 S1206X c.3617C>A 3749C>A 1 CFMDB R117C
i19 i22 IVS22 c.3717+12191C>T 3849+10kbC>T 58 IL17 various CF mutations
20 23 G1244R −2.62 c.3730G>C 3862G>C 1 CFMDB F508del
20 23 S1251N −2.28 c.3752G>A 3884G>A 0 IL19 x
20 23 L1258FfsX7 c.3773_3774insT 3905insT 0 IL19 x
20 23 V1272VfsX28 c.3816_3817delGT 3944delGT 1 CFMDB c.1392+1G>A
20 23 W1282X c.3846G>A 3978G>A 9 IL19 various CF mutations
21 24 N1303K −2.62 c.3909C>G 4041C>G 18 IL19 various CF mutations
22 25 V1327X c.3979delG 4111delG 1 Novel F508del
22 25 S1347PfsX13 c.4035_4038dupCCTA c.4167dupCCTA 1 CFMDB 2,3del21kb
23 26 Q1382X c.4144C>T 4276C>T 1 CFMDB F508del
23 26 Q1412X c.4234C>T 4366C>T 2 CFMDB F508del; c.1116+2T>A
i23 i26 IVS26_Donor c.4242+1G>T 4374+1G>T 1 CFMDB F508del
Sequence changes of uncertain pathogenic effect, tentatively counted as mutations
6A 6 E217G 0.30 c.650A>G 782A>G 1 CFMDB; rs1219109046 unknown
7 8 R352Q −0.01 c.1055G>A 1187G>A 1 CFMDB; rs121908753 F508del
7 8 Q359R 0.33 c.1076A>G 1208A>G 1 CFMDB F508del
i8 i9 IVS9 c.1210-12T5_1210-34_35 (TG)12 1332-12Tn_-34TGm 6 CFMDB F508del; 3x unknown
i8 i9 IVS9 c.1210-12T5_1210-34_35 (TG)13 1332-12Tn_-34TGm 2 CFMDB 2143delT; 1x unknown
i8 i9 IVS9 c.1210-12T8 1332-12Tn 1 Novel unknown
10 11 I506V −0.21 c.1516A>G 1648A>G 1 CFMDB; rs1800091 unknown
12 13 V562L 0.79 c.1684G>C 1816G>C 1 CFMDB; rs1800097 unknown
13 14 G723V 0.44 c.2168G>T 2300G>T 1 CFMDB; rs200531709 unknown
15 17 D924N 0.03 c.2770G>A 2902G>A 1 CFMDB; rs201759207 unknown
15 17 L967S 0.27 c.2900T>C 3032T>C 1 CFMDB; rs1800110 unknown
18 21 D1152H 0.50 c.3454G>C 3586G>C 1 CFMDB; rs75541969 F508del
Sequence changes considered as lacking pathogenic effect
4 4 I148T 2.04 c.443T>U 575T>U 4 IL19e unknown
13 14 I752V 0.35 c.2254A>G 2386A>G 1 Novelf F508
15 17 S912L 2.12 c.2735C>T 2867C>T 1 CFMDBg ; rs121909034 F508

Legend: a IL19 i 17 – mutations included in the INNOLiPA tests (see below); CFMDB – non-INNOLiPA mutations present in the CTFR mutation database; novel – mutations first reported in this study; b in three chromosomes R668C with G576A in trans; c F508del, c.1585-1G>A, G542X, N1303K or c.579+3A>G; d F508del, G542X, R553X or N1303K; e not pathogenic if not in cis with c.3067-72del6 (l.n.3199del6); f not pathogenic – see explanation the text; g not pathogenic if not in cis with G1244V.

a

Mutations detected by two INNOLiPA_CFTR tests (legacy names): IL19 (INNOLiPA_CFTR19): F508del; G542X; N1303K; W1282X; G551D; 1717-1G>A; R553X; CFTRdele2,3(21kb); I507del; 711+1G>T; 3272-26A>G; 3905insT; R560T; 1898+1G>A; S1251N; I148T; 3199del6; 3120+1G>A; Q552X.

IL17 (INNOLiPA_CFTR17_TnUpdate): 621+1G>T; 3849+10kbC>T; 2183AA>G; 394delTT; 2789+5G>A; R1162X; 3659delC; R117H; R334W; R347P; G85E; 1078delT; A455E; 2143delT; E60X; 2184delA; 711+5G>A; polymorphism 5T/7T/9T.